Euan McLeod

974 total citations
14 papers, 194 citations indexed

About

Euan McLeod is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Euan McLeod has authored 14 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Economics and Econometrics. Recurrent topics in Euan McLeod's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Diabetes Treatment and Management (4 papers). Euan McLeod is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Diabetes Treatment and Management (4 papers). Euan McLeod collaborates with scholars based in United Kingdom, United States and Germany. Euan McLeod's co-authors include Mazen Noureddin, Fady Ntanios, Deepa Malhotra, Birol Emir, Naim Alkhouri, João Morais, Raj Patel, Julia Lowin, Dominic Muston and Carlos Aguíar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Value in Health and Advances in Therapy.

In The Last Decade

Euan McLeod

13 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Euan McLeod United Kingdom 9 70 69 62 45 43 14 194
Alain Gay Germany 11 146 2.1× 183 2.7× 25 0.4× 19 0.4× 31 0.7× 22 369
Laura Napoleone Italy 9 60 0.9× 17 0.2× 92 1.5× 19 0.4× 14 0.3× 20 268
C. Kreilick United States 8 233 3.3× 73 1.1× 18 0.3× 65 1.4× 67 1.6× 15 343
Chrisly Dillon United States 9 162 2.3× 22 0.3× 31 0.5× 52 1.2× 35 0.8× 14 274
Felix Götzinger Germany 7 70 1.0× 21 0.3× 41 0.7× 59 1.3× 6 0.1× 21 180
Bernadette A Tumanan-Mendoza Philippines 8 75 1.1× 29 0.4× 21 0.3× 11 0.2× 21 0.5× 21 174
Juan Carlos Claro Chile 8 85 1.2× 12 0.2× 22 0.4× 60 1.3× 5 0.1× 14 311
José Moreno‐Arribas Spain 10 275 3.9× 64 0.9× 25 0.4× 52 1.2× 25 0.6× 34 338
Brian Jefferson United States 8 95 1.4× 16 0.2× 28 0.5× 30 0.7× 4 0.1× 12 186
Dagenais Gr Canada 7 121 1.7× 101 1.5× 47 0.8× 10 0.2× 11 0.3× 10 272

Countries citing papers authored by Euan McLeod

Since Specialization
Citations

This map shows the geographic impact of Euan McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euan McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euan McLeod more than expected).

Fields of papers citing papers by Euan McLeod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Euan McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euan McLeod. The network helps show where Euan McLeod may publish in the future.

Co-authorship network of co-authors of Euan McLeod

This figure shows the co-authorship network connecting the top 25 collaborators of Euan McLeod. A scholar is included among the top collaborators of Euan McLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Euan McLeod. Euan McLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Noureddin, Mazen, Fady Ntanios, Deepa Malhotra, et al.. (2022). Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning. Hepatology Communications. 6(7). 1537–1548. 53 indexed citations
2.
Lautsch, Dominik, Robert Boggs, Tongtong Wang, et al.. (2021). Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey. Advances in Therapy. 39(2). 1016–1032. 16 indexed citations
3.
4.
McNeill, Ann, Glenn Davies, Eliza Kruger, et al.. (2019). Ertugliflozin Compared to Other Anti-hyperglycemic Agents as Monotherapy and Add-on Therapy in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis. Diabetes Therapy. 10(2). 473–491. 20 indexed citations
5.
6.
7.
8.
McLeod, Euan, et al.. (2015). Cost of Illness, Diagnosis and treatment patterns for Diabetic Macular Edema across 13 Countries. Value in Health. 18(3). A181–A181. 1 indexed citations
9.
Morais, João, et al.. (2014). Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting. Revista Portuguesa de Cardiologia. 33(9). 535–544. 18 indexed citations
10.
Morais, João, et al.. (2014). Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting. SHILAP Revista de lepidopterología. 33(9). 535–544. 15 indexed citations
11.
McLeod, Euan, et al.. (2014). Economic Analysis of Rivaroxaban for the Treatment and Long-Term Prevention of Venous Thromboembolism in Portugal. Acta Médica Portuguesa. 27(5). 615–624. 8 indexed citations
12.
Fredrikson, S., Euan McLeod, Nathaniel Henry, et al.. (2013). A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden. Journal of Medical Economics. 16(6). 756–762. 5 indexed citations
13.
Kourlaba, Georgia, Nikos Maniadakis, Athanasios Giannoukas, et al.. (2012). PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece. Value in Health. 15(7). A372–A372. 1 indexed citations
14.
Beaudet, Amélie, et al.. (2010). Clinical and cost effectiveness of testosterone replacement in patients with type 2 diabetes mellitus and hypogonadism. Journal of Men s Health. 7(3). 289–289. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Gay Breakdown of academic impact, for papers by Laura Napoleone Breakdown of academic impact, for papers by C. Kreilick Breakdown of academic impact, for papers by Chrisly Dillon Breakdown of academic impact, for papers by Felix Götzinger Breakdown of academic impact, for papers by Bernadette A Tumanan-Mendoza Breakdown of academic impact, for papers by Juan Carlos Claro Breakdown of academic impact, for papers by José Moreno‐Arribas Breakdown of academic impact, for papers by Brian Jefferson Breakdown of academic impact, for papers by Dagenais Gr
Rankless by CCL
2026